サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426348

臨床試験管理システム（CTMS）の世界市場レポート 2024

Clinical Trial Management System (CTMS) Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床試験管理システム（CTMS）の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

臨床試験管理システム（CTMS）の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.7%の年間複合成長率（CAGR）で23億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、リアルタイムのデータアクセスの重視の高まり、電子カルテ（EHR）との統合の増加、仮想および分散型試験の増加、リスクベースのモニタリングの重視、分析および人工知能（AI）の進歩など、いくつかの主要な推進要因に起因しています。予測期間中に予想される注目すべき動向には、規制遵守とデータセキュリティへの重点化、適応型臨床試験デザインの出現、利害関係者関与のための共同プラットフォームの開発、リモートサイトの監視と管理の実装、データを進化させるための継続的な取り組みが含まれます。標準化を実現し、相互運用性を向上させます。これらの動向は総合的に、次期の成長予測に貢献します。

分散型臨床試験（DCT）の拡大は、臨床試験管理システム（CTMS）市場の成長を今後推進する重要な推進力となると予想されます。分散型臨床試験では遠隔医療と地域のヘルスケアサービスを活用し、患者が従来の病院ベースの治験会場を訪れる必要性を最小限に抑えるか排除します。 CTMSは、参加者の活動、募集を監視し、包括的な監視と報告を提供することにより、これらの試験を監督する上で重要な役割を果たします。2021年12月にClinical Trials Arenaが発表したレポートによると、2022年には分散型臨床試験とバーチャル臨床試験を組み合わせた臨床試験数が約1,300件に増加し、2021年の1,000件から28%増加すると予測されている。したがって、分散型臨床試験の増加傾向は、臨床試験管理システム（CTMS）市場の成長を大きく後押しするものと思われます。

個別化医療に対する需要の急増は、臨床試験管理システム（CTMS）市場の軌道を推進するもう1つの重要な要因となっています。個別化医療には、個人の遺伝子プロファイルを活用して、病気の予防、診断、治療に関する意思決定を調整することが含まれます。 CTMSは、各患者の特定のニーズに合わせて採用戦略、プロトコル設計、データ収集方法、患者関与アプローチ、およびデータ分析を適応させることにより、臨床試験プロセスをカスタマイズする上で極めて重要な役割を果たします。特に、個別化医療連合による2022年の進歩の範囲と重要性報告書で強調されているように、食品医薬品局（FDA）は2022年に12の個別化医療を承認し、これは新たに承認されたすべての治療用分子実体の約34％を占めます。この個別化医療に対する需要の急増は、臨床試験管理システム（CTMS）市場の拡大に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の臨床試験管理システム（CTMS）市場、システムタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • エンタープライズベースの臨床試験管理システム
  • サイトベースの臨床試験管理システム
  • 世界の臨床試験管理システム（CTMS）市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ソフトウェア
  • サービス
  • ハードウェア
  • 世界の臨床試験管理システム（CTMS）市場、提供モード別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • クラウドベースの臨床試験管理システム
  • Webベースの臨床試験管理システム
  • オンプレミス臨床試験管理システム
  • 世界の臨床試験管理システム（CTMS）市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社およびバイオ医薬品会社
  • 医療機器メーカー
  • 臨床研究機関（CRO）
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の臨床試験管理システム（CTMS）市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の臨床試験管理システム（CTMS）市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 臨床試験管理システム（CTMS）市場の競合情勢
  • 臨床試験管理システム（CTMS）市場企業プロファイル
    • The International Business Machines Corporation
    • Oracle Corporation
    • Laboratory Corporation of America Holdings
    • IQVIA Holdings Inc.
    • Wipro Limited

第31章 その他の大手および革新的な企業

  • ICON Public Limited Company
  • PAREXEL International Corporation
  • Veeva Systems Inc.
  • Bioclinica Inc.
  • Medidata Solutions Inc.
  • Calyx.ai
  • Clario Medical Imaging Inc.
  • Advarra Inc.
  • Bio-Optronics Inc.
  • MasterControl Inc.
  • ERT Clinical
  • iWeb Technologies Limited
  • Anju Software Inc.
  • Axiom Real-Time Metrics
  • EClinForce Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13360

A Clinical Trial Management System (CTMS) serves as a software platform specifically designed to streamline and enhance the management of clinical trials. This comprehensive solution is geared towards centralizing, organizing, and automating various facets of the clinical trial process, thereby facilitating efficient study planning, execution, monitoring, and reporting.

Two primary categories of Clinical Trial Management Systems are enterprise-based and site-based. An enterprise-based CTMS is a software solution implemented and utilized across an entire organization or enterprise. It serves as a centralized platform for managing all clinical trials conducted by the organization. The key components of a CTMS encompass software, services, and hardware, which are delivered through cloud-based, web-based, and on-premises modes. These solutions cater to the needs of pharmaceutical and biopharmaceutical companies, medical device manufacturers, clinical research organizations (CROs), and various other end-users involved in the clinical trial ecosystem.

The clinical trials management system (CTMS) research report is one of a series of new reports from The Business Research Company that provides clinical trials management system (CTMS) market statistics, including the clinical trials management system (CTMS)'s global market size, regional shares, competitors with a clinical trials management system (CTMS) market share, detailed clinical trials management system (CTMS) market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trials management system (CTMS). This clinical trials management system (CTMS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical trial management system (ctms) market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.41 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth observed during the historical period can be attributed to several key factors, including the escalating complexity of clinical trials, a rise in the number of global clinical trials, adherence to stringent regulatory compliance requirements, a heightened emphasis on patient-centric trials, and the growing trend of outsourcing clinical trials. These factors collectively contributed to the expansion witnessed in the past.

The clinical trial management system (ctms) market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The anticipated growth in the forecast period can be attributed to several key drivers, including a heightened emphasis on real-time data access, increased integration with Electronic Health Records (EHRs), a rise in virtual and decentralized trials, a focus on risk-based monitoring, and advancements in analytics and artificial intelligence (AI). Noteworthy trends expected in the forecast period include a strong focus on regulatory compliance and data security, the emergence of adaptive clinical trial designs, the development of collaborative platforms for stakeholder engagement, the implementation of remote site monitoring and management, and ongoing efforts to evolve data standards and improve interoperability. These trends collectively contribute to the projected growth in the coming period.

The expansion of decentralized clinical trials (DCTs) is anticipated to be a significant driver in propelling the growth of the clinical trial management system (CTMS) market moving forward. Decentralized clinical trials utilize telemedicine and local healthcare services, minimizing or eliminating the need for patients to visit traditional hospital-based trial locations. CTMS plays a crucial role in overseeing these trials by monitoring participant activities, recruitment, and providing comprehensive oversight and reporting. Notably, as per a report by Clinical Trials Arena in December 2021, the projected number of trials incorporating decentralized and virtual components is expected to soar to about 1,300 trials in 2022, marking a substantial 28% surge from the 1,000 trials recorded in 2021. Hence, the upward trend in decentralized clinical trials is poised to significantly fuel the growth of the clinical trial management system (CTMS) market.

The burgeoning demand for personalized medicine stands as another key factor propelling the trajectory of the clinical trial management system (CTMS) market. Personalized medicine involves leveraging an individual's genetic profile to tailor decisions regarding disease prevention, diagnosis, and treatment. CTMS plays a pivotal role in customizing the clinical trial process by adapting recruitment strategies, protocol designs, data collection methods, patient engagement approaches, and data analysis to suit the specific needs of each patient. Notably, as highlighted in the Scope and Significance of Progress in 2022 report by the Personalized Medicine Coalition, the Food and Drug Administration (FDA) approved 12 personalized medicines in 2022, accounting for approximately 34% of all newly approved therapeutic molecular entities. This surge in demand for personalized medicine significantly contributes to the expansion of the clinical trial management system (CTMS) market.

Concerns regarding data security have significantly contributed to the sluggish growth observed in the clinical trial management system (CTMS) market. These concerns encapsulate the risks and potential threats associated with safeguarding organizational data against unauthorized access, usage, disclosure, disruption, alteration, or destruction of digital assets. In the realm of CTMS, data security apprehensions act as a limiting factor by impeding the adoption of CTMS solutions, elevating associated costs, necessitating compliance with stringent regulations, and heightening susceptibility to cybersecurity threats. A pertinent example highlighting the impact of such concerns is the data breach encountered by the University of California, San Francisco (UCSF) in 2021, wherein personal information belonging to around 1,600 participants in a clinical trial was compromised. Consequently, these data security apprehensions significantly impede the expansion of the clinical trial management system (CTMS) market.

Key industry players in the clinical trial management system (CTMS) arena are driving innovation by introducing new technological platforms, particularly Software as a Service (SaaS) solutions integrated with artificial intelligence, to expedite drug development processes. SaaS-based CTMS represents a cloud-hosted software platform specifically designed to efficiently manage and oversee various facets of clinical trials. This approach enables accessibility from any location with an internet connection, diminishing the necessity for local software installations and streamlining maintenance efforts. For instance, in June 2023, Saama Technologies, Inc., a prominent US-based provider of clinical development software and services, unveiled a unified platform comprising SaaS-based products complementing their existing artificial intelligence and machine learning-based solutions. This innovative platform streamlines clinical development and commercialization processes by automating critical CTMS functions, slashing query generation times by up to 90%, and significantly reducing study data transformation and analysis durations. It provides a consolidated interface offering comprehensive insights into trial operations and patient progress, consolidating essential information into a singular, easily accessible location.

In March 2021, Advarra Inc., a prominent US-based entity specializing in clinical research, successfully acquired Bio-Optronics for an undisclosed sum. This strategic acquisition represents a significant enhancement to Advarra's existing capabilities by integrating Bio-Optronics' strengths into its portfolio. By joining forces, Advarra aims to bolster its offerings, delivering comprehensive solutions tailored for research institutions, sponsors, and contract research organizations. This integration is geared towards optimizing and streamlining the entire clinical research process, catering to the evolving needs and demands of the industry stakeholders. Bio-Optronics, a renowned US-based company focused on healthcare software and services.

Major companies operating in the clinical trial management system (ctms) market report are The International Business Machines Corporation, Oracle Corporation, Laboratory Corporation of America Holdings, IQVIA Holdings Inc., Wipro Limited, ICON Public Limited Company, PAREXEL International Corporation, Veeva Systems Inc., Bioclinica Inc., Medidata Solutions Inc., Calyx.ai, Clario Medical Imaging Inc., Advarra Inc., Bio-Optronics Inc., MasterControl Inc., ERT Clinical, iWeb Technologies Limited, Anju Software Inc., Axiom Real-Time Metrics, EClinForce Inc., MedNet Solutions Inc., DSG Inc., ArisGlobal LLC, DZS Clinical Services Inc., Datatrak International Inc., Nextrials Nc., SimpleTrials, PHARMASEAL International Limited, Crucial Data Solutions Inc., RealTime Software Solutions LLC

North America was the largest region in the clinical trial management system (CTMS) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial management system (ctms) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the clinical trial management system (ctms) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The clinical trial management system (CTMS) market includes revenues earned by entities by providing services such as study planning and design, site selection and management, patient recruitment and enrollment, clinical data management, and monitoring and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial management system (CTMS) market also includes sales of clinical trial analytics tools and mobile applications that are used in providing clinical trial management services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Management System (CTMS) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial management system (CTMS) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial management system (CTMS)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial management system (CTMS) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By System Type: Enterprise Clinical Trial Management System; On-Site Clinical Trial Management System
  • 2) By Component: Software; Service; Hardware
  • 3) By Delivery: Web-based (On-demand); Licensed Enterprise (On-premises); Cloud-based (SaaS)
  • 4) By End User: Large Pharma-biotech Companies; CROs; Medical Device Manufacturers; Small And Mid-sized Pharma-biotech Companies; Other End Users
  • Companies Mentioned: The International Business Machines Corporation; Oracle Corporation; Laboratory Corporation of America Holdings; IQVIA Holdings Inc.; Wipro Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Management System (CTMS) Market Characteristics

3. Clinical Trial Management System (CTMS) Market Trends And Strategies

4. Clinical Trial Management System (CTMS) Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Clinical Trial Management System (CTMS) Market Size and Growth

  • 5.1. Global Clinical Trial Management System (CTMS) Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Clinical Trial Management System (CTMS) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Clinical Trial Management System (CTMS) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Trial Management System (CTMS) Market Segmentation

  • 6.1. Global Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enterprise Based Clinical Trial Management System
  • Site Based Clinical Trial Management System
  • 6.2. Global Clinical Trial Management System (CTMS) Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Services
  • Hardware
  • 6.3. Global Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cloud Based Clinical Trial Management System
  • Web Based Clinical Trial Management System
  • On-Premise Clinical Trial Management System
  • 6.4. Global Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biopharmaceutical Companies
  • Medical Device Manufacturers
  • Clinical Research Organizations (CRO)
  • Other End-Users

7. Clinical Trial Management System (CTMS) Market Regional And Country Analysis

  • 7.1. Global Clinical Trial Management System (CTMS) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Clinical Trial Management System (CTMS) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Trial Management System (CTMS) Market

  • 8.1. Asia-Pacific Clinical Trial Management System (CTMS) Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Trial Management System (CTMS) Market

  • 9.1. China Clinical Trial Management System (CTMS) Market Overview
  • 9.2. China Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Trial Management System (CTMS) Market

  • 10.1. India Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Trial Management System (CTMS) Market

  • 11.1. Japan Clinical Trial Management System (CTMS) Market Overview
  • 11.2. Japan Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Trial Management System (CTMS) Market

  • 12.1. Australia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Trial Management System (CTMS) Market

  • 13.1. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Trial Management System (CTMS) Market

  • 14.1. South Korea Clinical Trial Management System (CTMS) Market Overview
  • 14.2. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Trial Management System (CTMS) Market

  • 15.1. Western Europe Clinical Trial Management System (CTMS) Market Overview
  • 15.2. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Trial Management System (CTMS) Market

  • 16.1. UK Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Trial Management System (CTMS) Market

  • 17.1. Germany Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Trial Management System (CTMS) Market

  • 18.5. France Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Trial Management System (CTMS) Market

  • 19.9. Italy Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Trial Management System (CTMS) Market

  • 20.13. Spain Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Trial Management System (CTMS) Market

  • 21.1. Eastern Europe Clinical Trial Management System (CTMS) Market Overview
  • 21.2. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Trial Management System (CTMS) Market

  • 22.1. Russia Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Trial Management System (CTMS) Market

  • 23.1. North America Clinical Trial Management System (CTMS) Market Overview
  • 23.2. North America Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Trial Management System (CTMS) Market

  • 24.1. USA Clinical Trial Management System (CTMS) Market Overview
  • 24.2. USA Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Trial Management System (CTMS) Market

  • 25.1. Canada Clinical Trial Management System (CTMS) Market Overview
  • 25.2. Canada Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Trial Management System (CTMS) Market

  • 26.1. South America Clinical Trial Management System (CTMS) Market Overview
  • 26.2. South America Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Trial Management System (CTMS) Market

  • 27.1. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Trial Management System (CTMS) Market

  • 28.1. Middle East Clinical Trial Management System (CTMS) Market Overview
  • 28.2. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Trial Management System (CTMS) Market

  • 29.1. Africa Clinical Trial Management System (CTMS) Market Overview
  • 29.2. Africa Clinical Trial Management System (CTMS) Market, Segmentation By System Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Clinical Trial Management System (CTMS) Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Clinical Trial Management System (CTMS) Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Trial Management System (CTMS) Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Trial Management System (CTMS) Market Competitive Landscape
  • 30.2. Clinical Trial Management System (CTMS) Market Company Profiles
    • 30.2.1. The International Business Machines Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Oracle Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Laboratory Corporation of America Holdings
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. IQVIA Holdings Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Wipro Limited
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Clinical Trial Management System (CTMS) Market Other Major And Innovative Companies

  • 31.1. ICON Public Limited Company
  • 31.2. PAREXEL International Corporation
  • 31.3. Veeva Systems Inc.
  • 31.4. Bioclinica Inc.
  • 31.5. Medidata Solutions Inc.
  • 31.6. Calyx.ai
  • 31.7. Clario Medical Imaging Inc.
  • 31.8. Advarra Inc.
  • 31.9. Bio-Optronics Inc.
  • 31.10. MasterControl Inc.
  • 31.11. ERT Clinical
  • 31.12. iWeb Technologies Limited
  • 31.13. Anju Software Inc.
  • 31.14. Axiom Real-Time Metrics
  • 31.15. EClinForce Inc.

32. Global Clinical Trial Management System (CTMS) Market Competitive Benchmarking

33. Global Clinical Trial Management System (CTMS) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Trial Management System (CTMS) Market

35. Clinical Trial Management System (CTMS) Market Future Outlook and Potential Analysis

  • 35.1 Clinical Trial Management System (CTMS) Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Clinical Trial Management System (CTMS) Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Clinical Trial Management System (CTMS) Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer